Open unicenter phase I trial of a combination therapy of temsirolimus and irinotecan in patients with glioblastoma or brain metastases of solid tumors.

Trial Profile

Open unicenter phase I trial of a combination therapy of temsirolimus and irinotecan in patients with glioblastoma or brain metastases of solid tumors.

Completed
Phase of Trial: Phase I

Latest Information Update: 30 Jun 2017

At a glance

  • Drugs Irinotecan (Primary) ; Temsirolimus (Primary)
  • Indications Brain metastases; Glioblastoma; Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 22 Nov 2016 Status changed from recruiting to completed.
    • 19 Jan 2012 Actual initiation date (Apr 2011) added as reported by German Clinical Trials Register.
    • 19 Jan 2012 Status changed from not yet recruiting to recruiting as reported by German Clinical Trials Register.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top